Bristol-Myers Squibb Company
Small molecule inhibitors of Galectin-3

Abstract:

The present disclosure relates to compounds of formula I, which inhibit Gal-3, and include pharmaceutically acceptable salts, compositions comprising such compounds, and methods using and making such compounds and compositions. ##STR00001##